Jamieson Wellness Inc.

Jamieson Wellness Inc.

JWEL.TO
Jamieson Wellness Inc.CA flagToronto Stock Exchange
41.81
CAD
-0.15
- -
1.73BMarket Cap
Jamieson Wellness Inc.
JWEL.TO
(Toronto Stock Exchange)

Recent

price

41.81

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
5.13
6.13
6.59
16.1
8.41
8.95
10.21
11.23
13.35
16.11
17.65
19.65
18.35
Revenue per Share
-0.88
-2.53
-0.67
-1.27
0.7
0.82
1.05
1.3
1.29
1.14
1.25
1.49
1.39
Basic EPS, GAAP
0.21
0.35
0.64
0.69
0.43
0.18
0.69
0.55
0.88
0.53
1.24
1.65
2.24
Free Cash Flow per Basic Share
- -
- -
- -
0.84
0.34
0.38
0.47
0.55
0.64
0.72
0.8
0.89
0.85
Dividend per Share
-0.87
-3.4
-4.07
11.54
6.02
6.47
7.2
8.15
9.58
9.37
10.23
10.13
9.85
Book Value per Share
-7.75
-10.11
-10.72
-5.7
-2.2
-1.61
-0.68
0.66
-5.09
-3.81
-2.8
-2.7
-3.19
Tangible Book Value per Share
38
38
38
19
38
39
40
40
41
42
42
42
42
Basic Weighted Avg Shares
193
231
248
301
320
345
404
451
547
676
734
822
766
Sales/Revenue/Turnover
5.53
11.06
12.5
14.95
14.45
16.07
15.75
16.86
15.2
12.92
12.79
13.84
13.04
Operating Margin (%)
7
7
8
9
9
11
12
14
17
20
19
20
19
Depreciation Expense
-33
-95
-25
-24
27
32
42
52
53
48
52
62
58
Net Income, GAAP
- -
- -
- -
- -
28.4
25.17
27.08
26.09
25.1
29.89
32.54
28.24
30.2
Effective Tax Rate (%)
-17.17
-41.32
-10.13
-7.91
8.34
9.18
10.31
11.55
9.65
7.08
7.07
7.6
7.57
Profit Margin (%)
-32
-131
-145
56
69
100
113
154
198
248
264
277
257
Working Capital
263
251
260
153
151
165
149
149
400
325
308
415
418
LT Debt
-33
-125
-152
221
241
259
292
342
432
481
548
530
511
Total Equity
- -
- -
- -
- -
8.28
9.91
10.6
11.93
9.35
7.44
7.58
9.03
7.95
Return on Invested Capital (%)
- -
- -
- -
- -
8.3
9.36
10.85
12.36
9.79
8.46
8.63
9.22
8.86
Return on Capital (%)
- -
- -
- -
- -
12.01
13.25
15.58
17.02
14.67
12.18
12.68
14.71
14.6
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
- -
- -
- -
LT Borrowings
308
295
418
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
42
42
42
Market Capitalization
1,524
1,273
1,483

Working Capital

FRC

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
437
361
420
Cash, Cash Equivalents & STI
45
41
51
Accounts Receivable, Net
227
127
163
Inventories
155
178
192
Total Current Liabilities
173
129
163
Payables & Accruals
142
98
140
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-12.98%
13.03%
-3.44%
Free Cash Flow
47.37%
33.86%
34.12%
Net Income, GAAP
-19.52%
9.19%
20.27%
Sales/Revenue/Turnover
13.71%
15.44%
12.03%
Total Cash Common Dividend
- -
14.87%
11.13%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
128
185
176
245
734
2025
146
199
278
- -
822
2026
170
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.1
0.21
0.25
- -
1.25
2025
-0.06
0.31
- -
- -
1.49
2026
0.21
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.19
0.19
0.21
- -
0.8
2025
0.21
0.21
- -
- -
0.89
2026
0.23
- -
- -
- -
- -
Business
Jamieson Wellness Inc. manufactures, distributes, markets, and sells branded natural health products including vitamins, minerals, supplements, and sports nutrition items; operates through the Jamieson Brands segment featuring flagship brands such as Jamieson, youtheory, Progressive Nutritional Therapies, Precision Sports Supplements, Smart Solutions, and Iron Vegan; and the Strategic Partners segment providing contract manufacturing, development, and packaging services to third-party consumer health companies and retailers. Founded in 1922 and headquartered in Toronto, Ontario, Canada, the company generates the majority of its revenue from its domestic Canadian market while expanding internationally across more than 50 countries, with notable operations in the United States, China, the Middle East, and Europe. Recent developments include accelerated growth in China through a strategic partnership with DCP Capital Partners, which drove over 50% growth in Q1 2025 and nearly 80% in 2024, bolstered by DCP's acquisition of Sun Art Retail Group for enhanced physical retail access; the redemption of its Series A Preference Shares in June 2025 to optimize capital structure; new product launches such as Ashwagandha Gummy and GLP-1 support products; and double-digit revenue increases, including 13.2% in Q3 2025 and 11.9% for full-year 2024, fueled by global brand expansion and e-commerce gains.

Company News

APIChatGPT
  • Jamieson Wellness Inc. Announces Senior Credit Facilities Refinancing